TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
BOLD

Boundless Bio, Inc.

Healthcare · Biotechnology

2.80$ +0.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Boundless Bio, Inc. (BOLD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 74 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BOLD
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
144 130 117 188 175 206 191 179 169 157 141 74
136 124 112 183 170 154 140 130 120 110 95 74
21 24 25 31 40 27 15 15 15 18 17 20
133 121 105 179 167 152 138 127 118 108 93 73
260 257 258 9.0 10 56 55 57 59 58 55 7.8
10 9.4 11 9.0 10 8.1 6.3 9.2 12 13 9.6 7.8
2.6 2.2 1.5 0.8 0.1 0.3 2.0 3.1 3.2 3.3
0.8 2.2 2.9 1.7 2.5 1.3 1.4 2.3 1.1 1.5 2.0 5.0
-116 -127 -141 179 165 151 137 123 110 99 86 66
-124 -136 -152 -169 -185 -201 -217 -233 -247 -260 -273 -297
22 22 22 22 22 17 22 22 22 22 22 22

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?